➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Express Scripts
Boehringer Ingelheim
Moodys
Harvard Business School

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

CAPTOPRIL AND HYDROCHLOROTHIAZIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Captopril And Hydrochlorothiazide patents expire, and when can generic versions of Captopril And Hydrochlorothiazide launch?

Captopril And Hydrochlorothiazide is a drug marketed by Cosette, Ivax Sub Teva Pharms, Mylan, Vintage Pharms Llc, and Watson Labs. and is included in five NDAs.

The generic ingredient in CAPTOPRIL AND HYDROCHLOROTHIAZIDE is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.

Summary for CAPTOPRIL AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for CAPTOPRIL AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for CAPTOPRIL AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
West China HospitalPhase 4
Vanderbilt University Medical CenterPhase 1/Phase 2
VA Office of Research and DevelopmentN/A

See all CAPTOPRIL AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for CAPTOPRIL AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for CAPTOPRIL AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074827-001 Dec 29, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 075055-004 Jun 18, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Cosette CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074827-003 Dec 29, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
AstraZeneca
Harvard Business School
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.